Work

Supplementary Methods from EC359: A First-in-Class Small-Molecule Inhibitor for Targeting Oncogenic LIFR Signaling in Triple-Negative Breast Cancer

Year: 2023
Type: supplementary-materials
Abstract: Supplementary methods section contain description of synthesis and characterization of EC330 and EC359, SPR studies, structural and sequence comparison of human and mouse LIFR, energy minimization of hLIFR, Protein and ligand preparation, molecular docking and MM-GBSA calculations, and molecular dynamics simulation.
Language: English
Open Access status: gold
OpenAlex ID: W4362494466
Cites:
Cited by:
Related to: 10